• Home
• Responsibility
• CR Report 2005
• Access to medicines
• Developing world
• Preferential pricing
• Eligibility for not-for-profit prices

Eligibility for not-for-profit prices

Our not-for-profit prices are targeted at those countries where the need is greatest and the available resources are most lacking. These are the Least Developed Countries (LDCs) and all of sub-Saharan Africa (SSA) – a total of 64 countries. In addition, all private employers in sub-Saharan Africa who provide care and treatment to their uninsured staff can purchase our ARVs at not-for-profit prices. The not-for-profit prices are also offered to all Country Co-ordinating Mechanism (CCM) projects¹ fully funded by the Global Fund and projects funded by the US President’s Emergency Plan for AIDS Relief (PEPFAR), in their 15 focus countries. In total our not-for-profit prices are therefore offered in over 100 countries.

In our target countries we also seek not-for-profit arrangements to facilitate access for core public employees such as teachers, nurses, police and fire-fighters who are not covered by private health insurance schemes.

We negotiate prices with the private health sector on a case-by-case basis. We depend on revenues from sales to the private market to maintain a local presence and much-needed infrastructure in developing countries. Without this local capacity we would be unable to provide essential services such as training healthcare workers to use our products, product support, safety monitoring and registration and launch of new products.

A list of products covered by not-for-profit prices and eligible countries is available in the background section on preferential pricing.

¹ The vast majority of Global Fund projects are Country Co-ordinating Mechanism (CCM) projects

Back to top